Cita APA (7a ed.)
Lapadula, G., Mezzadri, L., Lo Cascio, G., Antolini, L., Malandrin, S., Ranzani, A., . . . Bonfanti, P. (2024). Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: Results from a retrospective cohort study. Infection, 52(4), 1499-1510.
Cita Chicago Style (17a ed.)
Lapadula, Giuseppe, Luca Mezzadri, Giustina Lo Cascio, Laura Antolini, Sergio Malandrin, Alice Ranzani, Silvia Limonta, Annalisa Cavallero, y Paolo Bonfanti. "Anti-spike Antibody Level Is Associated with the Risk of Clinical Progression Among Subjects Hospitalized with COVID-19 Pneumonia: Results from a Retrospective Cohort Study." Infection 52, no. 4 (2024): 1499-1510.
Cita MLA (9a ed.)
Lapadula, Giuseppe, et al. "Anti-spike Antibody Level Is Associated with the Risk of Clinical Progression Among Subjects Hospitalized with COVID-19 Pneumonia: Results from a Retrospective Cohort Study." Infection, vol. 52, no. 4, 2024, pp. 1499-1510.
Precaución: Estas citas no son 100% exactas.